Long‐term effect of first‐line injectable multiple sclerosis treatments: Input of a time‐dependent propensity score

Author:

Lefort Mathilde12ORCID,Foucher Yohann34,Lenain Remi35,Vukusic Sandra6789,Edan Gilles210,Leray Emmanuelle1211

Affiliation:

1. Pharmaco‐epidemiology and health Services Research Department Rennes University, EHESP, REPERES – EA 7449 Rennes France

2. Neurology Department Univ Rennes, CHU Rennes, Inserm, CIC 1414 [(Centre d'Investigation Clinique de Rennes)] Rennes France

3. Biostatistic Department INSERM UMR 1246 – SPHERE, Nantes University, Tours University Nantes France

4. Nephrology Department Nantes University Hospital Nantes France

5. Nephrology Department Lille University Hospital Lille France

6. Neurology Department Hospices Civils de Lyon, Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro‐inflammation Bron France

7. Neurology Department Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 Lyon France

8. Neurology Department Université de Lyon, Université Claude Bernard Lyon 1 Lyon France

9. Neurology Department Eugène Devic EDMUS Foundation against Multiple Sclerosis, State‐Approved Foundation Bron France

10. Neurology Department CHU Pontchaillou Rennes France

11. METIS Department EHESP French School of Public Health Rennes France

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference39 articles.

1. Multiple sclerosis;Filippi M;Nat Rev,2018

2. LublinFD ReingoldSC CohenJA et al.Defining the clinical course of multiple sclerosis The 2013 Revisions.2014.

3. HAS.BETAFERON 250 ‐ Transparency committee.2010.

4. HAS.Copaxone ‐ Avis de la commission.2002.

5. Intramuscular interferon beta‐1atherapy initiated during a first demyelinating event in multiple sclerosis;Jacobs L;J Med,2000

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3